Related Experiment Video

Updated: Jun 26, 2026

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

Molecular mechanisms of TRP regulation in tumor growth and metastasis

Dimitra Gkika1, Natalia Prevarskaya

  • 1Inserm U800, Equipe labellisée par la Ligue Nationale Contre le Cancer, F59656 Villeneuve d'Ascq, France.

Biochimica Et Biophysica Acta
|December 24, 2008
PubMed

Insights

Transient Receptor Potential (TRP) channels regulate calcium, impacting cell death and growth. Their altered expression in tumors is linked to transcriptional changes, including hormones and growth factors, during cancer progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Transient Receptor Potential (TRP) channels are crucial regulators of intracellular calcium (Ca2+).
  • Aberrant intracellular Ca2+ levels are implicated in cell death, proliferation, and cancer development.
  • TRP channel expression and localization are frequently altered in tumors, affecting cancer cell behavior.

Purpose of the Study:

  • To review the transcriptional mechanisms that regulate Transient Receptor Potential (TRP) channel expression during tumorigenesis.
  • To highlight the role of hormones, growth factors, and alternative splicing in modulating TRP channel abundance in cancer.

Main Methods:

  • Literature review focusing on transcriptional regulation of TRP channels in cancer.
  • Analysis of studies investigating the impact of hormones, growth factors, and alternative splicing on TRP expression in tumors.

Main Results:

  • TRP channel expression is significantly modulated at the transcriptional level during tumor growth and metastasis.
  • Hormones, growth factors, and alternative splicing are key regulators influencing TRP channel abundance in cancer cells.
  • These transcriptional changes contribute to altered cellular functions, promoting tumorigenesis.

Conclusions:

  • Transcriptional regulation plays a vital role in altering TRP channel expression during cancer.
  • Understanding these mechanisms offers potential therapeutic targets for cancer treatment.
  • Further research into TRP channel regulation in tumorigenesis is warranted.

More Related Videos

Experimental Metastasis Assay08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...